Team:Washington/Gram Negative

From 2010.igem.org

(Difference between revisions)
Line 25: Line 25:
</html>
</html>
<!---------------------------------------PAGE CONTENT GOES BELOW THIS---------------------------------------->
<!---------------------------------------PAGE CONTENT GOES BELOW THIS---------------------------------------->
 +
'''Type VI Secretion'''
 +
Type VI Secretion is a recently discovered secretion system that has now been found in most gram-negative bacterial genomes.  Its hallmarks are two proteins, Hcp and VgrG, which form a "tube and spike" structure which is homologous to phage tail spikes.  Through secretion and assembly of these two proteins, effectors produced in the cytoplasm of the donor cell can be transported directly into the cytoplasm or periplasm of the recipient.
 +
The ''Pseudomonas aeruginosa'' genome includes a Type VI Secretion System (T6SS) which has been shown to target prokaryotic cells with a toxin (Hood, 2010). This toxin is not targeted to eukaryotic cells, and has been shown to kill gram-negative organisms in a cell contact-dependent manner.  Using this natural system, transported into a harmless enteric organism, we believe will allow for a new kind of defense against pathogenic enteric bacteria.
<!---------------------------------------PAGE CONTENT GOES ABOVE THIS---------------------------------------->
<!---------------------------------------PAGE CONTENT GOES ABOVE THIS---------------------------------------->

Revision as of 01:10, 9 September 2010

Type VI Secretion Type VI Secretion is a recently discovered secretion system that has now been found in most gram-negative bacterial genomes. Its hallmarks are two proteins, Hcp and VgrG, which form a "tube and spike" structure which is homologous to phage tail spikes. Through secretion and assembly of these two proteins, effectors produced in the cytoplasm of the donor cell can be transported directly into the cytoplasm or periplasm of the recipient.

The Pseudomonas aeruginosa genome includes a Type VI Secretion System (T6SS) which has been shown to target prokaryotic cells with a toxin (Hood, 2010). This toxin is not targeted to eukaryotic cells, and has been shown to kill gram-negative organisms in a cell contact-dependent manner. Using this natural system, transported into a harmless enteric organism, we believe will allow for a new kind of defense against pathogenic enteric bacteria.


Testing the Gram(+) Therapeutic       Designing the Gram(-) Therapeutic